[1] Bernal W, Jalan R, Quaglia A, et al. Acute-on-chronic liver failure. Lancet, 2015,386:1576-1587.
[2] 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南. 中华肝脏病杂志,2013,21:177-183.
[3] 郑锦辉, 孙蕾, 郑晓华. 小剂量糖皮质激素治疗乙型肝炎相关慢加急性肝衰竭早期疗效观察. 山东医药, 2014,54:51-53.
[4] Chen JF, Wang KW, Zhang SQ, et al. Dexamethasone in outcome of patients with hepatitis B virus-related acute-on-chronic liver failure. J Gastroenterol Hepatol, 2014,29:800-806.
[5] 伍利军, 李海华, 刘锦华. 肾上腺皮质激素治疗肝衰竭的疗效观察. 医学综述,2011,17:1110-1111.
[6] 朱萍, 邓国炯, 陈建新, 等. 给予肾上腺糖皮质激素治疗肝衰竭患者的时机与疗效观察. 实用肝脏病杂志, 2014,17:650-651.
[7] Zhang XQ, Jiang L, You JP, et al. Efficacy of short-term dexamethasone therapy in acute-on-chronic pre-liver failure. Hepatol Res, 2011,41:46-53.
[8] Fujiwara K, Yasui S, Yokosuka O. Corticosteroid and nucleoside analogue for hepatitis B virus-related acute liver failure. World J Gastroenterol, 2015,21:10485-10486.
[9] 汪萌, 聂青和. 糖皮质激素治疗重型肝炎肝衰竭患者的疗效及并发症临床荟萃分析. 临床肝胆病杂志,2012,28:764-770.
[10] Martin-Llahi M, Guevara M, Torre A, et al. Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology, 2011,140:488-496.
[11] Wasmuth HE, Kunz D, Yagmur E, et al. Patients with acute on chronic liver failure display "sepsis-like" immune paralysis. J Hepatol, 2005,42:195-201. |
